Gene · 7827
Papers2,376
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,376
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Network pharmacology, single-cell transcriptomics, machine learning and experimental validation identifying CHEK2 and HPGD as key therapeutic targets of berberine in diabetic nephropathy. | Funct Integr Genomics | 2026 | 42821141 | PubTator, text mining | PubMed |
| Functional characterization of genetic variants associated with rare inherited renal disorders in the Sri Lankan population. | Mol Genet Genomics | 2026 | 42814169 | PubTator, text mining | PubMed |
| Promoter Hypermethylation-Driven NPHS2 Silencing Promotes Immune Escape and Sunitinib Resistance in Clear Cell Renal Cell Carcinoma. | Oncol Res | 2026 | 42769428 | PubTator, text mining | PubMed |
| Kidney organoids as a platform to study plasminogen-induced injury and uPA-based therapies. | Stem Cells Transl Med | 2026 | 42768826 | PubTator, text mining | PubMed |
| A novel redox signalling axis mediates nicotine-induced podocyte injury. | Front Pharmacol | 2026 | 42661778 | PubTator, text mining | PubMed |
| Podocin oligomerization links slit-diaphragm architecture and NPHS2 genetics. | Kidney Int | 2026 | 42612985 | PubTator, text mining | PubMed |
| Anti-podocin and Anti-KIRREL1 Antibodies and Steroid Resistance, FSGS, and Disease Recurrence after Transplantation in Autoimmune Podocytopathies. | J Am Soc Nephrol | 2026 | 42490149 | PubTator, text mining | PubMed |
| LncRNA GATA3-AS1-mediated miR-2116-5p interaction modulates TCF12 and contributes to podocyte dysfunction in childhood nephrotic syndrome. | Clinics (Sao Paulo) | 2026 | 42462511 | PubTator, text mining | PubMed |
| Ubiquitination-Related Diagnostic Biomarkers for Diabetic Nephropathy: Insights From Multiomic Analysis, Drug Docking, and Experimental Validation. | FASEB J | 2026 | 42461218 | PubTator, text mining | PubMed |
| Selective JNK3 Inhibition Ameliorates TGF- β -Mediated Glomerular Injury and Fibrosis in the Kidneys. | J Am Soc Nephrol | 2026 | 42440378 | PubTator, text mining | PubMed |
| Bioinstructive Hybrid Scaffold Integrating Phosphoinositide 3-Kinase-Akt and Complementary Survival Pathways for Kidney Regeneration. | ACS Nano | 2026 | 42400932 | PubTator, text mining | PubMed |
| Suchilactone ameliorates podocyte injury in membranous nephropathy by modulating the JNK/p38 MAPK pathway in vitro. | Biochem Biophys Res Commun | 2026 | 42398336 | PubTator, text mining | PubMed |
| Diversion of Arginine's dietary metabolic fate in proteinuric kidney disease. | Res Sq | 2026 | 42370251 | PubTator, text mining | PubMed |
| Monogenic variants drive low recurrence risk in pediatric steroid-resistant nephrotic syndrome after kidney transplantation: a high-consanguinity cohort. | Pediatr Nephrol | 2026 | 42350677 | PubTator, text mining | PubMed |
| Pathogenic variants in COL4A3, COL4A4, JAG1, and NPHS2 genes in focal segmental glomerulosclerosis: Insights from targeted gene panel sequencing. | Mol Genet Metab Rep | 2026 | 42339201 | PubTator, text mining | PubMed |
| Beclin-1/LC3B regulation of podocyte autophagy in IgA nephropathy via PI3K/AKT signaling. | J Nephrol | 2026 | 42267911 | PubTator, text mining | PubMed |
| Expanding the Utility of Exome Sequencing in Preventive and Population Genetics. | Am J Med Genet A | 2026 | 42212615 | PubTator, text mining | PubMed |
| Nephrin is produced in visceral adipose tissue in humans and associates with insulin resistance. | Diabetes Res Clin Pract | 2026 | 42107718 | PubTator, text mining | PubMed |
| Thianthrenium Salts as Aryl Radical Precursors for Direct Arylation of β-Dicarbonyl Compounds via Electrochemical SRN1 Reaction. | Chemistry | 2026 | 42087726 | PubTator, text mining | PubMed |
| A biomimetic in vitro glomerular filtration barrier model for investigating renal barrier dysfunction in hyperglycemia. | Biomater Adv | 2026 | 41990583 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7827/papers